At a Glance
Third Rock Ventures is a venture capital firm based in Boston, MA founded in 2007. Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to… The firm focuses on Seed, Series A investments across sectors including Biotech. The firm manages $3B in assets under management. Notable portfolio companies include Foundation Medicine, Syros Pharmaceuticals, Editas Medicine, Bluebird Bio, Blueprint Medicines and Karuna Therapeutics. Creates and builds breakthrough biopharmaceutical companies by combining cutting-edge science with experienced drug development teams.
“Creates and builds breakthrough biopharmaceutical companies by combining cutting-edge science with experienced drug development teams.”
Mark Levin
Retired Founding Partner, Third Rock Ventures
Robert Tepper
Co-Founder and Partner, Third Rock Ventures
Third Rock Ventures primarily invests at the Seed, Series A stages. This means they focus on companies that are building their initial product and finding product-market fit.
Third Rock Ventures is headquartered in Boston, MA. Many of their portfolio companies are also based in this region, though they invest across geographies.
Third Rock Ventures focuses on investments in Biotech. Their portfolio reflects deep expertise and networks within these sectors.
Third Rock Ventures's typical investment check size ranges from $100K to $5M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Third Rock Ventures manages approximately $3B in assets under management (AUM) across their funds.